{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:34Z","timestamp":1783606954092,"version":"3.55.0"},"reference-count":37,"publisher":"Bioscientifica","issue":"6","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:p>Ectopic hormone secretion from neuroendocrine neoplasms in the lung (lung-NENs) is rare and poorly explored. Emerging evidence indicates that hormone-secreting NENs carry a worse prognosis. We hypothesised that ectopic hormone production and secretion in lung-NENs is a negative prognostic marker. A retrospective cohort of 167 patients with lung-NENs (121 females, median age: 68 (min\u2013max: 15\u201385) years), excluding small cell lung cancer, was analysed for clinical and biochemical data and outcome. Tumour tissue was evaluated for serotonin and calcitonin expression. Among 127 patients with hormone measurements, 52 had increased levels, with 5-hydroxyindoleacetic acid (5-HIAA) predominating (n = 38), followed by calcitonin (n = 20). There was no correlation between serotonin expression in tumour tissue and elevated levels of 5-HIAA, while high calcitonin levels were strongly correlated with calcitonin expression in tumour samples (OR: 21.86, P = 0.002). Furthermore, diffuse calcitonin staining was associated with a shorter overall survival (OS) (P = 0.036). Hormone-secreting tumours had a significantly shorter OS than non-secreting tumours (62 vs 124 months, P = 0.024), and multiple hormone secretion further worsened survival (33 vs 69 vs 124 months, P = 0.002). In multivariate analysis, multiple hormone secretion remained an independent negative prognostic factor (P = 0.042). In conclusion, hormone secretion in lung-NENs is associated with a shorter OS, particularly in patients with multiple hormone secretion. Diffuse calcitonin expression in tumour tissue is an additional negative prognostic marker. We recommend routine hormone testing at baseline and at disease progression in metastatic lung-NEN patients and suggest a more intensified therapeutic strategy in cases with detectable hormone secretion.<\/jats:p>","DOI":"10.1530\/erc-26-0142","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:40:30Z","timestamp":1780396830000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Hormone secretion predicts poor prognosis in lung neuroendocrine neoplasms"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-8013","authenticated-orcid":true,"given":"Ieva","family":"Lase","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eir","family":"L\u00f6fgren","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Hegedus","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Gr\u00f6nberg","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Welin","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tiensuu Janson","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"2026070909473632100_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026070909473632100_bib2","first-page":"127","volume-title":"Thoracic Tumours: WHO Classification of Tumours","author":"Travis","year":"2021","edition":"5th edn"},{"key":"2026070909473632100_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","article-title":"The 2021 WHO classification of lung tumors: impact of advances since 2015","volume":"17","author":"Nicholson","year":"2022","journal-title":"J Thorac Oncol"},{"key":"2026070909473632100_bib4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/his.15206","article-title":"Head-to-head: should Ki67 proliferation index be included in the formal classification of pulmonary neuroendocrine neoplasms?","volume":"85","author":"Pelosi","year":"2024","journal-title":"Histopathology"},{"key":"2026070909473632100_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/PAS.0000000000001358","article-title":"The role of histologic grading and Ki-67 index in predicting outcomes in pulmonary carcinoid tumors","volume":"44","author":"Dermawan","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"2026070909473632100_bib6","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/modpathol.2012.81","article-title":"Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors","volume":"25","author":"Walts","year":"2012","journal-title":"Mod Pathol"},{"key":"2026070909473632100_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J Thorac Oncol"},{"key":"2026070909473632100_bib8","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-15-2946","article-title":"Next-generation sequencing of pulmonary large cell neuroendocrine carcinoma reveals small cell carcinoma-like and non-small cell carcinoma-like subsets","volume":"22","author":"Rekhtman","year":"2016","journal-title":"Clin Cancer Res"},{"key":"2026070909473632100_bib9","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.path.2019.08.012","article-title":"Neuroendocrine tumors of the lung: updates and diagnostic pitfalls","volume":"12","author":"Hung","year":"2019","journal-title":"Surg Pathol Clin"},{"key":"2026070909473632100_bib10","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/annonc\/mdv041","article-title":"Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids","volume":"26","author":"Caplin","year":"2015","journal-title":"Ann Oncol"},{"key":"2026070909473632100_bib11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study","volume":"18","author":"Halperin","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026070909473632100_bib12","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1093\/annonc\/12.suppl_2.S83","article-title":"Ectopic ACTH syndrome: molecular bases and clinical heterogeneity","volume":"12","author":"Terzolo","year":"2001","journal-title":"Ann Oncol"},{"key":"2026070909473632100_bib13","doi-asserted-by":"crossref","first-page":"R173","DOI":"10.1530\/ERC-17-0036","article-title":"Paraneoplastic endocrine syndromes","volume":"24","author":"Dimitriadis","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"2026070909473632100_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/EC-21-0071","article-title":"Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis","volume":"10","author":"Llewellyn","year":"2021","journal-title":"Endocr Connect"},{"key":"2026070909473632100_bib15","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1530\/EJE-15-0917","article-title":"Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up","volume":"174","author":"Nozi\u00e8res","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2026070909473632100_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12020-018-1773-3","article-title":"Endocrine paraneoplastic syndromes in patients with neuroendocrine neoplasms","volume":"64","author":"Daskalakis","year":"2019","journal-title":"Endocrine"},{"key":"2026070909473632100_bib17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0022-5223(97)70182-X","article-title":"Bronchopulmonary carcinoid tumors associated with Cushing\u2019s syndrome: a more aggressive variant of typical carcinoid","volume":"114","author":"Shrager","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026070909473632100_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s42000-019-00163-z","article-title":"Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing\u2019s syndrome","volume":"19","author":"Lase","year":"2020","journal-title":"Hormones"},{"key":"2026070909473632100_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1210\/jc.2015-2436","article-title":"Multiple and secondary hormone secretion in patients with metastatic pancreatic neuroendocrine tumours","volume":"101","author":"Crona","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909473632100_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/M14-2132","article-title":"Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study","volume":"162","author":"de Mestier","year":"2015","journal-title":"Ann Intern Med"},{"key":"2026070909473632100_bib21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00428-019-02612-x","article-title":"ACTH-producing tumorlets and carcinoids of the lung: clinico-pathologic study of 63 cases and review of the literature","volume":"475","author":"La Rosa","year":"2019","journal-title":"Virchows Arch"},{"key":"2026070909473632100_bib22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/0284186X.2018.1441543","article-title":"Clinicopathological indicators of survival among patients with pulmonary carcinoid tumor","volume":"57","author":"Vesterinen","year":"2018","journal-title":"Acta Oncol"},{"key":"2026070909473632100_bib23","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2018.06.016","article-title":"Serotonin and human cancer: a critical view","volume":"161","author":"Sarrouilhe","year":"2019","journal-title":"Biochimie"},{"key":"2026070909473632100_bib24","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/ijms22031268","article-title":"Serotonin pathway in cancer","volume":"22","author":"Balakrishna","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026070909473632100_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1750","article-title":"Serotonin signalling in cancer: emerging mechanisms and therapeutic opportunities","volume":"14","author":"Chen","year":"2024","journal-title":"Clin Transl Med"},{"key":"2026070909473632100_bib26","doi-asserted-by":"crossref","first-page":"8519","DOI":"10.1158\/0008-5472.CAN-05-0848","article-title":"Calcitonin stimulates multiple stages of angiogenesis by directly acting on endothelial cells","volume":"65","author":"Chigurupati","year":"2005","journal-title":"Cancer Res"},{"key":"2026070909473632100_bib27","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1210\/me.2005-0284","article-title":"Calcitonin increases tumorigenicity of prostate cancer cells: evidence for the role of protein kinase A and urokinase-type plasminogen receptor","volume":"20","author":"Thomas","year":"2006","journal-title":"Mol Endocrinol"},{"key":"2026070909473632100_bib28","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jtho.2019.02.002","article-title":"Characterization, prognosis, and treatment of patients with metastatic lung carcinoid tumors","volume":"14","author":"Robelin","year":"2019","journal-title":"J Thorac Oncol"},{"key":"2026070909473632100_bib29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/01.meg.0000230091.76168.f9","article-title":"Digestive calcitonin-secreting tumors of the foregut: comparison with non-calcitonin-secreting tumors","volume":"18","author":"Wuilmet","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026070909473632100_bib30","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0046-8177(89)90103-2","article-title":"Immunohistochemical analysis of calcitonin and calcitonin gene-related peptide in human lung","volume":"20","author":"Tsutsumi","year":"1989","journal-title":"Hum Pathol"},{"key":"2026070909473632100_bib31","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3390\/jcm9051363","article-title":"Serotonin-secreting neuroendocrine tumours of the pancreas","volume":"9","author":"Milanetto","year":"2020","journal-title":"J Clin Med"},{"key":"2026070909473632100_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/cen.13364","article-title":"Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours","volume":"87","author":"Zandee","year":"2017","journal-title":"Clin Endocrinol"},{"key":"2026070909473632100_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/jne.70174","article-title":"European Society of neuroendocrine tumors (ENETS) 2025 guidance paper for lung and thymic carcinoids","volume":"38","author":"Baudin","year":"2026","journal-title":"J Neuroendocrinol"},{"key":"2026070909473632100_bib34","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1530\/ERC-16-0538","article-title":"Effect of hormone secretory syndromes on neuroendocrine tumor prognosis","volume":"24","author":"Zandee","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"2026070909473632100_bib35","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/sj.bjc.6603699","article-title":"The prognostic role of WHO classification, urinary 5-hydroxyindoleacetic acid and liver function tests in metastatic neuroendocrine carcinomas of the gastroenteropancreatic tract","volume":"96","author":"Formica","year":"2007","journal-title":"Br J Cancer"},{"key":"2026070909473632100_bib36","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2217\/fon-2018-0960","article-title":"Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysis","volume":"15","author":"Joish","year":"2019","journal-title":"Future Oncol"},{"key":"2026070909473632100_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1530\/EJE-16-0392","article-title":"Limited value for urinary 5-HIAA excretion as prognostic marker in gastrointestinal neuroendocrine tumours","volume":"175","author":"Zandee","year":"2016","journal-title":"Eur J Endocrinol"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/6\/ERC-26-0142.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/6\/ERC-26-0142.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0142\/519940\/erc-26-0142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-26-0142\/519940\/erc-26-0142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:47:49Z","timestamp":1783604869000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/6\/e260142\/77577\/Hormone-secretion-predicts-poor-prognosis-in-lung"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-26-0142","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"article-number":"e260142"}}